Search Results for "Butal Acet Caff 50 325 40mg"

07:08 EST 23rd November 2014 | BioPortfolio

Original Source: Butalbital, Acetaminophen and Caffeine [Cardinal Health]

BUTALBITAL, ACETAMINOPHEN AND CAFFEINE TABLETS, USP 50 mg/325 mg/40 mg

Matching Channels

None

Matching News

Biota ends laninamivir in flu after trial failure

The Atlanta, Georgia-based company reported on 1 August that neither the 40mg nor the 80mg dose of LANI, a long-acting neuraminidase inhibitor, provided a statistically significant reduction in the me...

AbbVie's Humira shines in skin disease with no competitors

Results from Period A of PIONEER I, which were presented at the 44th Annual European Society for Dermatological Research (ESDR) Meeting on 11 September in Copenhagen, showed that moderate-to-severe HS...

Ranbaxy's generic Nexium exclusivity: dead or alive?

But the absence of a definitive statement on whether this means Ranbaxy has lost out on the exclusivity opportunity for esomeprazole magnesium delayed-release capsules 20mg and 40mg, as in the case of...

December decision for resubmitted Pozen NDA

PA8140 and PA32540 contain 40mg immediate-release doses of the proton pump inhibitor omeprazole layered around either 81mg or 325mg doses of aspirin wrapped in a pH-sensitive coating. Pozen is seeking...

Teva to sue Dr Reddy’s over Copaxone patent infringement

Global generics leader Teva Pharmaceutical Industries yesterday confirmed that it has received the first paragraph IV notice for its three-times-a-week Copaxone (glatiramer acetate) injection 40mg/mL ...

Mylan launches generic Micardis in USA

US generic drugmaker Mylan has launched Telmisartan Tablets USP, 20mg, 40mg and 80mg, the generic version of family-owned German pharma major Boehringer Ingelheim's Micardis tablets.

Biota releases top-line results from Phase II trial of laninamivir octanoate

US-based Biota Pharmaceuticals has reported top-line data from a Phase II clinical trial comparing the safety and efficacy of a 40mg and 80mg dose of laninamivir octanoate (LANI) with placebo.

Momenta's ANDA for generic Copaxone accepted for review by FDA

The US Food and Drug Administration (FDA) has accepted for review the abbreviated new drug application (ANDA) of Momenta Pharmaceuticals's three-times-a-week generic Copaxone (glatiramer acetate injec...

Matching PubMed Articles

Decreased IK1 and increased ryanodine receptor sensitivity synergistically contribute to sustained focal arrhythmia in the intact rabbit heart.

Heart failure (HF) results in dramatic electrophysiological remodeling, including increased sensitivity of ryanodine receptors (RyR) and decreased inward rectifying K(+) current (IK1), which predispos...

Formation and reduction of furan in Maillard reaction model systems consisting of various sugars/amino acids/furan precursors.

To investigate the effect of temperature on the formation of furan, various furan models were conducted at 90, 121, and 150°C. A total 15 models, including alanine (ALA), serine (SER), ribose (RIB), ...

Effects of short-term exposure to fluoxetine and carbamazepine to the collembolan Folsomia candida.

Pharmaceuticals, emerging environmental contaminants, have their ecotoxicological effects to non-target organisms in soil largely unknown. This study assessed short-term effects of two human pharmaceu...

1-Carb-oxy-naphthalen-2-yl acetate monohydrate.

In the title compound, C13H10O4·H2O, both the carboxylic acid [Car-Car-C-O = -121.1 (2)°, where ar = aromatic] and the ester [Car-Car-O-C = -104.4 (3)°] groups lie out of the mean plane of the ...

Withdrawal-related adverse events from clinical trials of clobazam in Lennox-Gastaut syndrome.

To assess withdrawal-related adverse event (AE) rates following abrupt clobazam discontinuation in Phase I trials and gradual clobazam tapering (2-3weeks) following discontinuation from III trials met...

Search Whole site using Google

Loading
Search BioPortfolio:
Loading
Advertisement
Advertisement
Advertisement Advertisement